Wednesday, February 10, 2010, 11:04AM AEST - The Australian Stockmarket closes in 5 hours and 1 minute.
To create a watchlist or portfolio of shares, Register

Anika Therapeutics Inc. (ANIK)

7:58AM AEST: 6.49 USD  Up 0.09 (1.41%)  
 MORE ON ANIK 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Anika Therapeutics Inc. (NasdaqNM:ANIK) Delayed quote dataEdit
Last Trade:6.49 USD
Trade Time: 7:58AM AEST
Change:Up 0.09 (1.41%)
Prev Close:6.40
Open:6.46
Bid:6.10 x 1800
Ask:7.46 x 100
1y Target Est:18.00
Day's Range:6.42 - 6.53
52wk Range:3.00 - 9.25
Volume:11,321
Avg Vol (3m):47,669.4
Market Cap:74.23M
P/E (ttm):18.28
EPS (ttm):0.36
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add ANIK to Portfolio   Download Data

 HEADLINES 
Anika Therapeutics to Discuss Acquisition of Fidia Advanced Biopolymers During Special Conference Call Today
Business Wire (Mon, Jan 4)
Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
Business Wire (Fri, Jan 1)
Anika gets European approval on wrinkle product
AP (Fri, Nov 20)
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Business Wire (Fri, Nov 20)
ANIKA THERAPEUTICS INC Financials
EDGAR Online Financials (Sun, Nov 8)
ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Nov 4)
Anika Therapeutics Earnings Call scheduled for 9:00 am ET today
CCBN (Thu, Oct 29)
ANIKA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
EDGAR Online (Wed, Oct 28)
ANIKA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Sep 15)
ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Aug 6)
More Headlines for ANIK...

 ANALYST 
EPS Est (next year) (Dec-09) :N/A
EPS Est (in 2 years) (Dec-10) :N/A
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices